Logo image of HEMP.CA

HEMPALTA CORP (HEMP.CA) Stock Fundamental Analysis

TSX-V:HEMP - TSX Venture Exchange - CA42371M1041 - Common Stock - Currency: CAD

0.06  +0.01 (+20%)

Fundamental Rating

0

Taking everything into account, HEMP scores 0 out of 10 in our fundamental rating. HEMP was compared to 0 industry peers in the Unkown industry. HEMP has a bad profitability rating. Also its financial health evaluation is rather negative. HEMP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HEMP has reported negative net income.
In the past year HEMP has reported a negative cash flow from operations.
HEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFHEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -149.96%
ROE -246.4%
ROIC N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEMP.CA Yearly ROA, ROE, ROICHEMP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -50 -100 -150

1.3 Margins

HEMP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HEMP.CA Yearly Profit, Operating, Gross MarginsHEMP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

1

2. Health

2.1 Basic Checks

HEMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HEMP has been increased compared to 1 year ago.
HEMP has a worse debt/assets ratio than last year.
HEMP.CA Yearly Shares OutstandingHEMP.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
HEMP.CA Yearly Total Debt VS Total AssetsHEMP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -3.69, we must say that HEMP is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.46 indicates that HEMP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -3.69
ROIC/WACCN/A
WACC8.15%
HEMP.CA Yearly LT Debt VS Equity VS FCFHEMP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

A Current Ratio of 1.58 indicates that HEMP should not have too much problems paying its short term obligations.
HEMP has a Quick Ratio of 1.58. This is a bad value and indicates that HEMP is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.76
HEMP.CA Yearly Current Assets VS Current LiabilitesHEMP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

HEMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3720.00%.
EPS 1Y (TTM)-3720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HEMP.CA Yearly Revenue VS EstimatesHEMP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K 400K 500K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HEMP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HEMP.CA Price Earnings VS Forward Price EarningsHEMP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HEMP.CA Per share dataHEMP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HEMP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEMPALTA CORP

TSX-V:HEMP (5/9/2025, 7:00:00 PM)

0.06

+0.01 (+20%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners20.83%
Ins Owner ChangeN/A
Market Cap5.70M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.34
P/FCF N/A
P/OCF N/A
P/B 2.04
P/tB 2.56
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -149.96%
ROE -246.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.76
Altman-Z -3.69
F-Score2
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3781.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5671.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4439.2%
OCF growth 3YN/A
OCF growth 5YN/A